New Phase Appoints Renowned U.S. Cancer Expert Prof. Jeff Geschwind to Scientific Advisory Board for Oncology Treatment

Summary

New Phase, a clinical-stage medical device company, appointed Prof. Jeff Geschwind, a renowned U.S. cancer expert in interventional oncology, to its Scientific Advisory Board to support FDA discussions and feasibility study preparations.